JPH0532535A - Coating film type skin protecting agent - Google Patents

Coating film type skin protecting agent

Info

Publication number
JPH0532535A
JPH0532535A JP21281991A JP21281991A JPH0532535A JP H0532535 A JPH0532535 A JP H0532535A JP 21281991 A JP21281991 A JP 21281991A JP 21281991 A JP21281991 A JP 21281991A JP H0532535 A JPH0532535 A JP H0532535A
Authority
JP
Japan
Prior art keywords
parts
copolymer
skin
isopropanol
film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP21281991A
Other languages
Japanese (ja)
Other versions
JP3212637B2 (en
Inventor
Eiji Kobayashi
英司 小林
Hisayoshi Kaneko
尚義 金子
Tomoaki Uesugi
知明 上杉
Minoru Yoshino
稔 吉野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zenyaku Kogyo KK
Original Assignee
Zenyaku Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zenyaku Kogyo KK filed Critical Zenyaku Kogyo KK
Priority to JP21281991A priority Critical patent/JP3212637B2/en
Publication of JPH0532535A publication Critical patent/JPH0532535A/en
Application granted granted Critical
Publication of JP3212637B2 publication Critical patent/JP3212637B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE:To obtain a skin protecting agent capable of forming a thin transparent coating film, having good feeling in use, excellent water resistance, readily washable with alkali soap. CONSTITUTION:A coating film type skin protecting agent substantially comprising (a) about 1-3 pts.wt. copolymer of methyl methacrylate and methacrylic acid in a ratio of 2:1, (b) about 0.05-0.6 pt.wt. terpolymer of ethyl acrylate, methyl methacrylate and methacryloyloxyethyl trimethylammonium chloride in a ratio of 1:2:0.1 and (c) the rest of a hydrous alcohol.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、公知アクリル系共重合
体を組み合わせることにより、耐水性及びアルカリ可溶
性の被膜を形成しうる皮膚保護剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a skin protectant capable of forming a water-resistant and alkali-soluble film by combining known acrylic copolymers.

【0002】[0002]

【従来の技術】皮膚病の中で特に主婦湿疹に代表される
手湿疹が多数発生して、問題となってからかなりの年月
がたつが、現在でもその数はいっこうに減らない状況に
ある。この疾患は、台所用中性洗剤等の脱脂力の強い家
庭用洗剤により、皮膚から皮脂が過剰に除去されて外部
からの刺激を受けやすい状態になった結果発生したり、
美容師や機械工、農作業等の職業において、ヘアダイ、
機械油、農薬等の皮膚に有害な物質に頻繁に接触するこ
とにより発生する。
2. Description of the Related Art It has been quite a while since many hand rashes such as housewife's eczema occurred among skin diseases, and it has been a problem for a long time, but the number is still declining. . This disease occurs as a result of the excessive removal of sebum from the skin by a household detergent with strong degreasing power, such as a kitchen neutral detergent, making it more susceptible to external irritation,
In hair profession, mechanic, profession such as farming, hair dye,
It is caused by frequent contact with skin-toxic substances such as machine oil and pesticides.

【0003】この疾患の治療にはステロイド剤の外用、
油分の補給、皮脂分泌促進剤の使用、保湿剤配合外用剤
の使用、皮膚構成成分の補給等が行われている。また、
予防としては、洗剤やその他の有害物質との接触を断つ
ため、炊事、洗濯の際のゴム又はビニール手袋の着用
や、それに代る被膜形成タイプの皮膚保護剤が利用され
ている。
Topical steroids for the treatment of this disease,
Replenishment of oils, use of sebum secretagogues, use of external preparations containing moisturizers, replenishment of skin constituents and the like are performed. Also,
As a preventive measure, in order to prevent contact with detergents and other harmful substances, rubber or vinyl gloves are worn during cooking and washing, and a film-forming type skin protectant is used instead.

【0004】特に、被膜形成タイプの皮膚保護剤は、皮
膚表面に塗布又はスプレーすることにより被膜を形成
し、皮膚の保護を図るものである。従来、被膜形成タイ
プの皮膚保護剤としてはシリコン系の基剤を使用したも
の、セルロース誘導体を強力な有機溶媒に溶解したも
の、新規アクリル系ポリマーを使用したもの等が知られ
ている。シリコン系の基剤を用いた場合は被膜形成が十
分とはいえず、塗布時のべとつきや水、油によって皮膚
表面から容易に除去される等の問題があった。セルロー
ス誘導体を用いた場合は、その溶媒であるアセトン、酢
酸エチル等が皮膚・粘膜を刺激したり、あるいは形成さ
れた被膜を皮膚から除去することが容易ではない等の問
題があった。従来から医薬品のフィルムコーティング基
剤に使用され、安全性が高いことが知られているアクリ
ル系共重合体については、最近、被膜型外用剤組成物の
主基剤として皮膚への応用(特開平3−77820号、
特開平3−128316号)が提案されている。しか
し、いずれの場合も有効成分の経皮吸収促進または調節
を主目的として被膜の特性を定めているため、これらを
被膜形成タイプの皮膚保護剤として用いたとき、中性洗
剤に対する被膜強度が不十分であったり、耐水性や使用
感に劣る等の点からも被膜形成タイプの皮膚保護剤の用
途には不向きであった。しかし、先頃、前記用途の基剤
として公知のアクリル系重合体の欠点を改良した新規ア
クリル系共重合体(特公平2−9006号)が提案され
たが、未だ十分とは言えない。
In particular, the film-forming type skin protectant is intended to form a film by applying or spraying on the skin surface to protect the skin. Heretofore, as film-forming type skin protectants, those using a silicone base, those dissolving a cellulose derivative in a strong organic solvent, and those using a novel acrylic polymer have been known. When a silicon-based base was used, film formation was not sufficient, and there were problems such as stickiness during application and easy removal from the skin surface by water and oil. When a cellulose derivative is used, there are problems that the solvent such as acetone and ethyl acetate irritates the skin and mucous membranes, or it is not easy to remove the formed film from the skin. Acrylic copolymers, which have been conventionally used as film coating bases for pharmaceuticals and are known to have high safety, have recently been applied to the skin as the main base of film-type external preparation compositions (JP 3-77820,
JP-A-3-128316) has been proposed. However, in all cases, the characteristics of the coating are defined mainly for the purpose of promoting or controlling the percutaneous absorption of the active ingredient, and therefore, when these are used as skin-protecting agents of the film-forming type, the film strength against neutral detergent is unsatisfactory. It was not suitable for use as a film-forming type skin protector because it was sufficient and was inferior in water resistance and usability. However, recently, a new acrylic copolymer (Japanese Patent Publication No. 2-9006) in which the drawbacks of known acrylic polymers as the base material for the above-mentioned applications are improved has been proposed, but it is still not sufficient.

【0005】[0005]

【発明が解決しようとする課題】本発明者らは、被膜型
皮膚保護剤に望まれる特性として、 1)薄く透明な被膜を形成できること 2)耐水性があって、アルカリ石鹸で皮膚面から容易に
除去できること 3)伸びのあるフィルムを作り、皮膚に密着すること 4)臭い及び刺激性の少ないこと 5)中性洗剤を透過しないこと 6)アルコール又は含水アルコールに溶解すること 7)通気性及び水蒸気透過性があって、被覆時にむれ
ず、べとつかず、ツッパリ感のないこと 8)塗布後、比較的短時間に乾くこと 等に注目して鋭意研究を進めた結果、従来より医薬品の
フィルムコーティング基剤として利用され、安全性は高
いが皮膚保護剤には不向きとされていた公知のアクリル
系共重合体を組み合わせることで、皮膚保護剤として望
まれる上記特性を発揮することを見出し、本発明を完成
した。
DISCLOSURE OF THE INVENTION The present inventors have found that the following properties are desired for a film-type skin protectant: 1) A thin and transparent film can be formed. 2) It has water resistance and can be easily applied from the skin surface with an alkaline soap. 3) Make a stretchable film and adhere to the skin 4) Have little odor and irritation 5) Do not penetrate neutral detergent 6) Dissolve in alcohol or hydrous alcohol 7) Breathability and It has water vapor permeability, does not get sticky during coating, does not get sticky, and does not feel slippery. 8) As a result of intensive research, we focused on the fact that it dries in a relatively short time after application. It is used as a base, and by combining known acrylic copolymers that are highly safe but unsuitable for skin protectants, the above properties desired as skin protectants can be obtained. The present invention has been completed by finding that it can be exerted.

【0006】[0006]

【課題を解決するための手段】すなわち、本発明は、 a)メタアクリル酸メチルとメタアクリル酸の2:1の
共重合体約1〜3部 b)アクリル酸エチルとメタアクリル酸メチルとメタア
クリル酸塩化トリメチルアンモニウムエチルとの1:
2:0.1の共重合体及び/又は1:2:0.2の共重
合体約0.05〜0.6部 c)含水アルコール残余量 を基本組成とする被膜型皮膚保護剤であり、更に好まし
くは、 a)メタアクリル酸メチルとメタアクリル酸の2:1の
共重合体約1〜3部 a’)メタアクリル酸メチルとメタアクリル酸の1:1
の共重合体約6部以下〔但し、a)とa’)の共重合体
の合計は約1〜7部〕 b)アクリル酸エチルとメタアクリル酸メチルとメタア
クリル酸塩化トリメチルアンモニウムエチルとの1:
2:0.1の共重合体及び/又は1:2:0.2の共重
合体約0.05〜0.6部 c)含水アルコール残余量 を基本組成とする被膜型皮膚保護剤である。
Means for Solving the Problems That is, the present invention comprises: a) about 1 to 3 parts of a 2: 1 copolymer of methyl methacrylate and methacrylic acid b) ethyl acrylate, methyl methacrylate and meta 1: with trimethylammonium ethyl acrylate
A copolymer of 2: 0.1 and / or a copolymer of 1: 2: 0.2 about 0.05 to 0.6 parts c) A film-type skin protectant having a basic composition of residual amount of hydrous alcohol. And more preferably, a) about 2 to 1 part of a 2: 1 copolymer of methyl methacrylate and methacrylic acid a ') 1: 1 of methyl methacrylate and methacrylic acid.
About 6 parts or less (however, the sum of the copolymers of a) and a ') is about 1 to 7 parts) b) of ethyl acrylate, methyl methacrylate and trimethylammonium ethyl methacrylate. 1:
2: 0.1 copolymer and / or 1: 2: 0.2 copolymer about 0.05 to 0.6 parts c) A film-type skin protectant having a basic composition of residual amount of hydrous alcohol. .

【0007】[0007]

【作用】本発明の皮膚保護剤は、皮膚に塗布することで
疎水性の無色透明な薄い被膜を短時間に形成し、通気性
及び水蒸気透過性を有して長時間外界からの刺激物に対
して皮膚を保護し、また被膜除去に際してはアルカリ石
鹸で容易に洗い流すことができる等の特性を有してい
る。
The skin protective agent of the present invention forms a hydrophobic colorless transparent thin film in a short time when applied to the skin, has breathability and water vapor permeability, and is a stimulant from the outside for a long time. On the other hand, it has the property of protecting the skin and being able to be easily washed off with an alkaline soap when removing the film.

【0008】本発明で用いるa)、a’)、b)の共重
合体はいずれも公知であり、医薬品のフィルムコーティ
ング基剤として従来より幅広く利用されている。a)及
びa’)の共重合体はいずれも平均分子量が約13.5
万であり、それぞれpH7以上及びpH6以上で水に溶
解するため、腸溶性基剤として従来より使用されている
高分子化合物である。b)の共重合体は平均分子量が約
15万であり、pH非依存性で水に不溶であるため、徐
放性基剤として従来より使用されている高分子化合物で
ある。上記の共重合体はいずれもドイツのレーム・ファ
ーマ社(Roehm Pharma GmbH)より
a)がオイドラギットS、たとえばS100、a’)が
オイドラギットL、たとえばL100、b)がオイドラ
ギットRS、たとえばRS100、RSPM、RS10
0L、RSPML等の商品名で市販されている。
The copolymers a), a ') and b) used in the present invention are all known and have been widely used as a film coating base for pharmaceuticals. The copolymers a) and a ') both have an average molecular weight of about 13.5.
Since it is soluble in water at pH 7 or higher and pH 6 or higher, it is a polymer compound conventionally used as an enteric base. The copolymer b) has an average molecular weight of about 150,000, is pH-independent and is insoluble in water, and is therefore a polymer compound conventionally used as a sustained-release base. In each of the above-mentioned copolymers, a) is Eudragit S, for example, S100, a ') from Germany's Röhm Pharma GmbH, Eudragit L, for example, L100, b) is Eudragit RS, for example, RS100, RSPM, RS10
It is marketed under the trade name of 0L, RSPML and the like.

【0009】上記配合成分のうち、a)の共重合体、
b)の共重合体及び含水アルコールが必須成分である。
a)の共重合体は配合量が少ないと被膜強度が不十分で
容易に皮膚から被膜がはがれ易く、多いと塗布時にツッ
パリ感や白色化等の不快感を与える被膜性状となるた
め、本発明の皮膚保護剤においては、約1〜3部の配合
が適当である。b)の共重合体は配合することで被膜の
強度又は透過性能を調整することができるが、配合量が
少なすぎると被膜が薄すぎて皮膚から容易にはがれ、多
すぎると皮膚に強く付着して、アルカリ石鹸で容易に除
去できないため、約0.05〜0.6部の配合が適当で
あり、特に約0.1〜0.2部の配合が好ましい。な
お、a)の共重合体に対するb)の共重合体の配合比率
は約1/60〜3/5である。
Of the above-mentioned components, the copolymer of a),
The copolymer of b) and hydrous alcohol are essential components.
When the amount of the copolymer a) is small, the film strength is insufficient and the film is easily peeled off from the skin. In the skin protectant of (1), about 1 to 3 parts is suitable. By blending the copolymer of b), the strength or permeability of the coating can be adjusted, but if the blending amount is too small, the coating will be too thin to peel off easily from the skin, and if too large, it will adhere strongly to the skin. Since it cannot be easily removed with an alkaline soap, a blending amount of about 0.05 to 0.6 part is suitable, and a blending amount of about 0.1 to 0.2 part is particularly preferable. The blending ratio of the copolymer of b) to the copolymer of a) is about 1/60 to 3/5.

【0010】本発明の皮膚保護剤で用いるアルコールと
しては、エタノール、イソプロパノール等が挙げられ
る。これらは単独又は組み合わせて使用してもよい。な
お、本発明の皮膚保護剤塗布時の乾燥時間を調整するた
めに、水を加えて含水アルコール溶液とすることができ
るが、水の量は皮膚保護剤に対して約1〜30%が適当
である。
Examples of the alcohol used in the skin protectant of the present invention include ethanol and isopropanol. These may be used alone or in combination. In order to adjust the drying time at the time of applying the skin protectant of the present invention, water can be added to make a hydroalcoholic solution, but the amount of water is preferably about 1 to 30% with respect to the skin protectant. Is.

【0011】本発明の皮膚保護剤の使用感(被膜透明
性、ツッパリ感等)を更に改善したり、アルカリ石鹸に
よる被膜除去を更に容易にする目的で、上記必須成分に
加えて上記a’)の共重合体を配合し得る。この場合、
上記a’)の共重合体の配合量は、皮膚保護剤に対して
単独では約6部以下が適当であるが、被膜のツッパリ感
や白色化を防ぐために、a)の共重合体との配合量合計
を約1〜7部とすることが適当である。
In order to further improve the feeling of use of the skin protectant of the present invention (transparency of coating, smooth feeling, etc.) and to facilitate removal of the coating with an alkaline soap, the above a ') is added in addition to the above essential components. Can be blended. in this case,
The blending amount of the copolymer of a ') above is appropriately about 6 parts or less for the skin protecting agent alone, but in order to prevent the skin from feeling tingling and whitening, It is suitable to make the total amount of compounding about 1 to 7 parts.

【0012】本発明の皮膚保護剤には所望に応じてセル
ロース誘導体や可塑剤を配合してもよい。セルロース誘
導体としてはエチルセルロース、ヒドロキシプロピルセ
ルロース、メチルセルロース、ヒドロキシプロピルメチ
ルセルロース等が挙げられ、特にエチルセルロース、ヒ
ドロキシプロピルセルロースが好ましい。セルロース誘
導体は皮膚保護剤を塗布する際に必要な部位以外の箇所
に被膜が広がることを防止するのに有用で、その配合量
は約2部以下、好ましくは約0.4〜0.8部である。
可塑剤としてはクエン酸トリエチル、ポリエチレングリ
コール、フタル酸ジエチル、1,3−ブチレングリコー
ル、ジプロピレングリコール又はトリアセチン等が挙げ
られ、これらを単独で又は組み合わせて配合してもよ
い。上記可塑剤のうち特にクエン酸トリエチル、1,3
−ブチレングリコールが好ましい。これらの可塑剤によ
って、形成される被膜の厚さを調整することができ、そ
の配合量は約15部以下、好ましくは約3〜10部であ
る。
If desired, the skin protectant of the present invention may contain a cellulose derivative or a plasticizer. Examples of the cellulose derivative include ethyl cellulose, hydroxypropyl cellulose, methyl cellulose, hydroxypropyl methyl cellulose and the like, with ethyl cellulose and hydroxypropyl cellulose being particularly preferable. The cellulose derivative is useful for preventing the coating film from spreading to a part other than the necessary part when applying the skin protectant, and the compounding amount thereof is about 2 parts or less, preferably about 0.4 to 0.8 part. Is.
Examples of the plasticizer include triethyl citrate, polyethylene glycol, diethyl phthalate, 1,3-butylene glycol, dipropylene glycol and triacetin, and these may be blended alone or in combination. Of the above plasticizers, especially triethyl citrate, 1,3
-Butylene glycol is preferred. The thickness of the formed film can be adjusted by these plasticizers, and the amount thereof is about 15 parts or less, preferably about 3 to 10 parts.

【0013】また所望に応じて、本発明の皮膚保護剤に
皮膚に好ましい薬効成分、たとえば外用の医薬品、医薬
部外品又は化粧品等で使用されているγ−オリザノー
ル、酢酸トコフェロール、グリチルレチン酸等を更に配
合してもよい。
Further, if desired, the skin protective agent of the present invention may include a medicinal ingredient preferable for skin, such as γ-oryzanol, tocopherol acetate, glycyrrhetinic acid, etc. which are used in external medicines, quasi drugs or cosmetics. You may further mix.

【0014】なお、本発明の皮膚保護剤で用いられてい
る公知アクリル系共重合体、すなわち上記a)、
a’)、b)を組み合わせて被膜を形成させる先行技術
は薬剤のフィルムコーティング分野で「持続性製剤用薬
物放出制御膜」として提案されている(特開平3−72
38号)。しかし、この場合はb)の共重合体配合割合
がa)及びa’)の共重合体混合物に対して約1.5〜
5.7倍と高く、本発明の同配合割合約0.6倍以下と
は大きく異なっている。この提案の代表的組成物(比較
例6及び7)を用いて皮膚保護剤としての特性を確かめ
たが、皮膚に強く付着しアルカリ石鹸では容易に除去で
きないことが示されたため、この先行技術は皮膚保護剤
の用途に不向きであることが判明した。
The known acrylic copolymer used in the skin protectant of the present invention, that is, the above a),
The prior art in which a ') and b) are combined to form a film has been proposed as a "drug-release controlling film for sustained-release preparations" in the field of film coating of drugs (JP-A-3-72).
No. 38). However, in this case, the blending ratio of the copolymer of b) is about 1.5 to the copolymer mixture of a) and a ').
It is as high as 5.7 times, which is significantly different from the same mixing ratio of the present invention of about 0.6 times or less. The properties of the proposed composition (Comparative Examples 6 and 7) as a skin protectant were confirmed, but it was shown that the composition strongly adheres to the skin and cannot be easily removed with an alkaline soap. It turned out to be unsuitable for the use of skin protectants.

【0015】[0015]

【実施例】以下に実施例、比較例を挙げて本発明を更に
具体的に説明するが、本発明はこれに限定されるもので
はない。
EXAMPLES The present invention will be described in more detail with reference to Examples and Comparative Examples, but the present invention is not limited thereto.

【0016】実施例1 クエン酸トリエチル3部に精製水を20部加え、更にイ
ソプロパノールを50部混合した中に、オイドラギット
S100を1.5部、L100を1.5部、RS100
Lを0.1部及びヒドロキシプロピルセルロースを0.
6部順次溶解し、イソプロパノールで全量とする。
Example 1 20 parts of purified water was added to 3 parts of triethyl citrate, and 50 parts of isopropanol was further mixed, and then, 1.5 parts of Eudragit S100, 1.5 parts of L100 and RS100.
L to 0.1 part and hydroxypropylcellulose to 0.
Dissolve 6 parts sequentially and make up to the total amount with isopropanol.

【0017】実施例2 イソプロパノール50部に精製水を10部加え、オイド
ラギットS100を1部及びRSPMLを0.5部順次
溶解し、イソプロパノールで全量とする。
Example 2 10 parts of purified water was added to 50 parts of isopropanol, 1 part of Eudragit S100 and 0.5 part of RSPML were sequentially dissolved, and isopropanol was added to the total amount.

【0018】実施例3 クエン酸トリエチル0.5部にエタノールを20部加
え、更にイソプロパノールを50部混合した中に、オイ
ドラギットS100を1.5部、L100を1.5部、
RSPMLを0.5部及び1,3−ブチレングリコール
を2部順次溶解・混合し、イソプロパノールで全量とす
る。
Example 3 To 0.5 part of triethyl citrate, 20 parts of ethanol was added, and further 50 parts of isopropanol were mixed, 1.5 parts of Eudragit S100 and 1.5 parts of L100,
0.5 parts of RSPML and 2 parts of 1,3-butylene glycol are sequentially dissolved and mixed, and the total amount is made up with isopropanol.

【0019】実施例4 イソプロパノール50部に精製水を20部加え、更にオ
イドラギットS100を1.5部、L100を1.5
部、RSPMLを0.1部順次溶解し、イソプロパノー
ルで全量とする。
Example 4 20 parts of purified water was added to 50 parts of isopropanol, 1.5 parts of Eudragit S100 and 1.5 parts of L100.
Parts and RSPML are sequentially dissolved in 0.1 part, and the total amount is made up with isopropanol.

【0020】実施例5 クエン酸トリエチル3部に精製水を20部加え、更にイ
ソプロパノールを50部混合した中に、オイドラギット
S100を1.5部、L100を1.5部、RSPML
を0.1部順次溶解し、イソプロパノールで全量とす
る。
Example 5 To 3 parts of triethyl citrate was added 20 parts of purified water, and 50 parts of isopropanol was further mixed. Then, 1.5 parts of Eudragit S100, 1.5 parts of L100 and RSPML were mixed.
0.1 part is sequentially dissolved, and the total amount is made up with isopropanol.

【0021】実施例6 クエン酸トリエチル5部に精製水を30部加え、更にイ
ソプロパノールを50部混合した中に、オイドラギット
S100を1部、L100を6部、RS100を0.1
部及びエチルセルロースを0.1部順次溶解し、イソプ
ロパノールで全量とする。
Example 6 To 5 parts of triethyl citrate was added 30 parts of purified water, and 50 parts of isopropanol was further mixed, and 1 part of Eudragit S100, 6 parts of L100 and 0.1 parts of RS100 were mixed.
Parts and 0.1 parts of ethyl cellulose are sequentially dissolved, and the total amount is made up with isopropanol.

【0022】実施例7 クエン酸トリエチル3部に精製水を20部加え、更にイ
ソプロパノールを50部混合した中に、オイドラギット
S100を3部、RS100Lを0.2部及びヒドロキ
シプロピルセルロースを0.6部順次溶解し、イソプロ
パノールで全量とする。
Example 7 To 3 parts of triethyl citrate was added 20 parts of purified water, and 50 parts of isopropanol was further mixed. 3 parts of Eudragit S100, 0.2 part of RS100L and 0.6 part of hydroxypropyl cellulose were mixed. Dissolve in order and make up to the total volume with isopropanol.

【0023】実施例8 クエン酸トリエチル3部に精製水を20部加え、更にイ
ソプロパノールを50部混合した中に、オイドラギット
S100を3部、RS100を0.2部及びヒドロキシ
プロピルセルロースを0.6部順次溶解し、イソプロパ
ノールで全量とする。
Example 8 To 3 parts of triethyl citrate was added 20 parts of purified water, and 50 parts of isopropanol was further mixed, and then, 3 parts of Eudragit S100, 0.2 part of RS100 and 0.6 part of hydroxypropyl cellulose were mixed. Dissolve in order and make up to the total volume with isopropanol.

【0024】実施例9 クエン酸トリエチル3部に精製水を20部加え、更にイ
ソプロパノールを50部混合した中に、オイドラギット
S100を3部、RS100を0.3部、RSPMLを
0.3部及びヒドロキシプロピルセルロースを0.6部
順次溶解し、イソプロパノールで全量とする。
Example 9 20 parts of purified water was added to 3 parts of triethyl citrate, and 50 parts of isopropanol was further mixed, 3 parts of Eudragit S100, 0.3 part of RS100, 0.3 part of RSPML and hydroxy. 0.6 parts of propylcellulose are sequentially dissolved, and the total amount is made up with isopropanol.

【0025】実施例10 クエン酸トリエチル8部にエタノールを28部加え、更
にイソプロパノールを50部混合した中に、オイドラギ
ットS100を1.5部、L100を1.5部、RSP
MLを0.1部、ヒドロキシプロピルセルロースを0.
6部及びγ−オリザノールを0.5部順次溶解し、イソ
プロパノールで全量とする。
Example 10 To 8 parts of triethyl citrate, 28 parts of ethanol was added, and further 50 parts of isopropanol were mixed, 1.5 parts of Eudragit S100, 1.5 parts of L100 and RSP were mixed.
0.1 part of ML and 0.
6 parts and 0.5 part of γ-oryzanol are sequentially dissolved, and the total amount is made up with isopropanol.

【0026】比較例1 フタル酸ジエチル1.5部に精製水を20部加え、更に
イソプロパノールを50部混合した中に、オイドラギッ
トS100を3部及びヒドロキシプロピルセルロースを
1部順次溶解し、イソプロパノールで全量とする。
Comparative Example 1 To 1.5 parts of diethyl phthalate, 20 parts of purified water was added, and 50 parts of isopropanol was further mixed. Then, 3 parts of Eudragit S100 and 1 part of hydroxypropylcellulose were sequentially dissolved, and isopropanol was added to the whole amount. And

【0027】比較例2 クエン酸トリエチル3部に精製水を20部加え、更にイ
ソプロパノールを50部混合した中に、オイドラギット
L100を4部及びヒドロキシプロピルセルロースを
0.6部順次溶解し、イソプロパノールで全量とする。
COMPARATIVE EXAMPLE 2 4 parts of Eudragit L100 and 0.6 parts of hydroxypropylcellulose were sequentially dissolved in 3 parts of triethyl citrate and 20 parts of purified water and 50 parts of isopropanol, and the total amount was added with isopropanol. And

【0028】比較例3 クエン酸トリエチル3部に精製水を20部加え、更にイ
ソプロパノールを50部混合した中に、オイドラギット
S100を1.5部、L100を1.5部及びヒドロキ
シプロピルセルロースを0.6部順次溶解し、イソプロ
パノールで全量とする。
Comparative Example 3 20 parts of purified water was added to 3 parts of triethyl citrate, and 50 parts of isopropanol was further mixed. Then, 1.5 parts of Eudragit S100, 1.5 parts of L100 and 0.1 parts of hydroxypropyl cellulose were added. Dissolve 6 parts sequentially and make up to the total amount with isopropanol.

【0029】比較例4 クエン酸トリエチル3部に精製水を20部加え、更にイ
ソプロパノールを50部混合した中に、オイドラギット
L100を3部、RSPMLを0.1部及びヒドロキシ
プロピルセルロースを0.6部順次溶解し、イソプロパ
ノールで全量とする。
Comparative Example 4 3 parts of triethyl citrate was added with 20 parts of purified water, and 50 parts of isopropanol was further mixed, and then, 3 parts of Eudragit L100, 0.1 part of RSPML and 0.6 part of hydroxypropyl cellulose were mixed. Dissolve in order and make up to the total volume with isopropanol.

【0030】比較例5 クエン酸トリエチル3部に精製水を20部加え、更にイ
ソプロパノールを50部混合した中に、オイドラギット
L100を3部、RS100を0.1部及びヒドロキシ
プロピルセルロースを0.6部順次溶解し、イソプロパ
ノールで全量とする。
Comparative Example 5 3 parts of triethyl citrate was added with 20 parts of purified water, and 50 parts of isopropanol was further mixed. 3 parts of Eudragit L100, 0.1 part of RS100 and 0.6 part of hydroxypropyl cellulose were added. Dissolve in order and make up to the total volume with isopropanol.

【0031】比較例6 クエン酸トリエチル3部に精製水を20部加え、更にイ
ソプロパノールを50部混合した中に、オイドラギット
S100を1.5部、L100を1.5部及びRS10
0を4.5部順次溶解し、イソプロパノールで全量とす
る。
Comparative Example 6 20 parts of purified water was added to 3 parts of triethyl citrate, and 50 parts of isopropanol was further mixed, and then 1.5 parts of Eudragit S100, 1.5 parts of L100 and RS10.
4.5 parts of 0 are sequentially dissolved, and the total amount is made up with isopropanol.

【0032】比較例7 クエン酸トリエチル3部に精製水を20部加え、更にイ
ソプロパノールを50部混合した中に、オイドラギット
S100を0.5部、L100を0.5部、RS100
Lを1部、RS100を3部及びヒドロキシプロピルセ
ルロースを0.6部順次溶解し、イソプロパノールで全
量とする。
COMPARATIVE EXAMPLE 7 20 parts of purified water was added to 3 parts of triethyl citrate, and 50 parts of isopropanol was further mixed, 0.5 parts of Eudragit S100, 0.5 parts of L100 and RS100 were mixed.
1 part of L, 3 parts of RS100 and 0.6 parts of hydroxypropylcellulose are sequentially dissolved, and the total amount is made up with isopropanol.

【0033】比較例8 エタノール60部にオイドラギットL100を1部加え
て溶解し、この溶液に精製水を37部とイソプロパノー
ル1部との混合液を加えて均一になるまで撹拌して液剤
を得る。
Comparative Example 8 1 part of Eudragit L100 was added to 60 parts of ethanol to dissolve, and a mixed solution of 37 parts of purified water and 1 part of isopropanol was added to this solution and stirred until a uniform solution was obtained.

【0034】[0034]

【発明の効果】本発明の被膜型皮膚保護剤の特性を確か
めるために、本発明の必須成分である公知アクリル系共
重合体を含まない組成物と本発明と配合割合の異なる公
知アクリル系共重合体の組合せに関する先行技術の代表
的組成物を対照として下記各試験を行った。
To confirm the characteristics of the film-type skin protectant of the present invention, a composition not containing a known acrylic copolymer which is an essential component of the present invention and a known acrylic copolymer having a different blending ratio from the present invention are used. The following tests were carried out with a representative composition of the prior art relating to the polymer combination as a control.

【0035】検体:実施例1〜10の組成物(本発明の
皮膚保護剤組成物) 比較例1〜3の組成物(上記b)の共重合体を含まない
組成物) 比較例4,5の組成物(上記a)の共重合体を含まない
組成物) 比較例6,7の組成物(特開平3−7238号の代表的
組成物) 比較例8の組成物(特開平3−77820号の代表的組
成物)
Specimens: Compositions of Examples 1 to 10 (skin protectant compositions of the present invention) Compositions of Comparative Examples 1 to 3 (compositions containing no copolymer of the above b)) Comparative Examples 4 and 5 (Composition containing no copolymer of the above a)) Compositions of Comparative Examples 6 and 7 (Representative compositions of JP-A-3-7238) Compositions of Comparative Example 8 (JP-A-3-77820) Representative composition of No.)

【0036】試験例1(官能試験) 上記各検体を人の手の甲に塗布し、塗布時の接着性及び
粘着性と乾燥後の接着性、透明性、伸び、ツッパリ感に
関する官能試験を行い、その結果を表1に示す。
Test Example 1 (Sensory Test) Each of the above samples was applied to the back of a human hand, and a sensory test was conducted on the adhesiveness and tackiness at the time of application and the adhesiveness after drying, transparency, elongation, and feeling of smoothness. The results are shown in Table 1.

【0037】試験例2(洗浄試験) 色素として銅クロロフィリンナトリウム1%水溶液を手
の甲に塗布し、乾燥後その上に上記各検体を塗布する。
乾燥後、アルカリ石鹸で洗浄して被膜が除去されたか否
かを色素の残量から肉眼的に確かめ、その結果を表1に
示す。
Test Example 2 (Washing test) A 1% aqueous solution of sodium copper chlorophyllin as a dye is applied to the back of a hand, and after drying, each of the above samples is applied.
After drying, it was washed with an alkaline soap to visually confirm from the remaining amount of the dye whether or not the coating was removed, and the results are shown in Table 1.

【0038】試験例3(被膜強度試験) 上記各検体を入れた密封容器中に、それぞれ直径17m
mのガラス玉を入れ、表面を十分に濡らした後室温で風
乾する。精製水900mlに台所用中性洗剤5mlを加
えて調製した試験液(pH約7.7)を、補助盤付の崩
壊試験器(日本薬局方の崩壊試験法に記載)に注入し、
上記の被覆済みガラス玉を入れて20分間上下運動させ
た後、ガラス玉を取り出し被覆の状態を肉眼的に確かめ
る。その結果は表1に示す。
Test Example 3 (Film Strength Test) Each of the above specimens was placed in a hermetically sealed container and had a diameter of 17 m.
After putting a glass ball of m into the surface of the glass, the surface of the glass ball was sufficiently wet and then air-dried at room temperature. A test solution (pH about 7.7) prepared by adding 5 ml of kitchen neutral detergent to 900 ml of purified water is injected into a disintegration tester with an auxiliary plate (described in the disintegration test method of the Japanese Pharmacopoeia),
After putting the above coated glass beads and moving up and down for 20 minutes, the glass beads are taken out and the state of coating is visually confirmed. The results are shown in Table 1.

【0039】[0039]

【表1】 [Table 1]

【0040】上記各試験の結果、本発明の皮膚保護剤は
a)の共重合体及び/又はb)の共重合体を含まない比
較例1〜5の組成物に比べて、官能特性及び中性洗剤に
対する被膜強度の点で明らかに優れていた。また、b)
の共重合体の配合割合が多い内服剤フィルムコーティン
グ(特開平3−7238号)の代表的組成物(比較例
6,7)に比べて、アルカリ石鹸による被膜除去が極め
て容易であった点から明らかに優れていた。更に、被膜
型外用剤(特開平3−77820号)の有効成分を除い
た代表的被膜組成物(比較例8)に比べて、中性洗剤に
対する被膜強度の点で明らかに優れていた。
As a result of the above-mentioned tests, the skin protectant of the present invention had a sensory characteristic and a medium level as compared with the compositions of Comparative Examples 1 to 5 which did not contain the copolymer a) and / or the copolymer b). It was clearly superior in terms of film strength against a mild detergent. Also, b)
In comparison with the representative compositions (Comparative Examples 6 and 7) of the oral film coating (Japanese Patent Application Laid-Open No. 3-7238) in which the proportion of the copolymer is large, the removal of the coating with the alkaline soap was extremely easy. It was clearly excellent. Further, it was clearly superior in the film strength to a neutral detergent as compared with the representative film composition (Comparative Example 8) in which the active ingredient of the film-type external preparation (JP-A-3-77820) was removed.

【0041】以上のごとく、本発明の皮膚保護剤は、従
来より皮膚保護用の被膜形成には不向きとされていた公
知アクリル系共重合体の割合を限定して組み合わせるこ
とにより、薄く、使用感がよく、中性洗剤を透過せず、
耐水性に優れかつアルカリ石鹸による洗浄が容易等の予
想外に良好な皮膚保護用の被膜特性を発揮するに至っ
た。従って、本発明の皮膚保護剤は家庭の主婦、職業的
な器具洗浄者又は薬液使用者等の手湿疹防止又は治療の
補助として利用可能である。
As described above, the skin protectant of the present invention is thin and has a feeling of use when it is combined by limiting the proportion of known acrylic copolymers, which have been conventionally unsuitable for forming a film for skin protection. Good, does not penetrate neutral detergent,
It has come to exhibit unexpectedly good film properties for skin protection such as excellent water resistance and easy cleaning with alkaline soap. Therefore, the skin protectant of the present invention can be used as an adjunct to the prevention or treatment of hand eczema for housewives at home, professional equipment cleaners, or users of liquid medicine.

Claims (8)

【特許請求の範囲】[Claims] 【請求項1】 実質的に下記基本成分からなる被膜型皮
膚保護剤。 a)メタアクリル酸メチルとメタアクリル酸の2:1の
共重合体約1〜3部 b)アクリル酸エチルとメタアクリル酸メチルとメタア
クリル酸塩化トリメチルアンモニウムエチルとの1:
2:0.1の共重合体及び/又は1:2:0.2の共重
合体約0.05〜0.6部 c)含水アルコール残余量
1. A film-type skin protectant essentially consisting of the following basic components. a) about 2 to 1 part of a 2: 1 copolymer of methyl methacrylate and methacrylic acid b) 1: 1 of ethyl acrylate, methyl methacrylate and trimethylammonium ethyl methacrylate.
2: 0.1 copolymer and / or 1: 2: 0.2 copolymer about 0.05 to 0.6 parts c) hydrous alcohol residual amount
【請求項2】 a)の共重合体が平均分子量約13.5
万で、pH7以上の水に溶解する請求項1記載の皮膚保
護剤。
2. The copolymer of a) has an average molecular weight of about 13.5.
The skin protectant according to claim 1, which is soluble in water having a pH of 7 or more.
【請求項3】 b)の共重合体が平均分子量約15万
で、pH非依存性で水に不溶である請求項1〜2記載の
皮膚保護剤。
3. The skin protectant according to claim 1, wherein the copolymer b) has an average molecular weight of about 150,000, is pH-independent and is insoluble in water.
【請求項4】 アルコールがエタノール又はイソプロパ
ノールである請求項1〜3記載の皮膚保護剤。
4. The skin protective agent according to claim 1, wherein the alcohol is ethanol or isopropanol.
【請求項5】 実質的に下記基本成分からなる被膜型皮
膚保護剤。 a)メタアクリル酸メチルとメタアクリル酸の2:1の
共重合体約1〜3部 a’)メタアクリル酸メチルとメタアクリル酸の1:1
の共重合体約6部以下〔但し、a)とa’)の共重合体
の合計は約1〜7部〕 b)アクリル酸エチルとメタアクリル酸メチルとメタア
クリル酸塩化トリメチルアンモニウムエチルとの1:
2:0.1の共重合体及び/又は1:2:0.2の共重
合体約0.05〜0.6部 c)含水アルコール残余量
5. A film-type skin protectant essentially consisting of the following basic components. a) 2: 1 copolymer of methyl methacrylate and methacrylic acid about 1-3 parts a ') 1: 1 of methyl methacrylate and methacrylic acid
About 6 parts or less (however, the sum of the copolymers of a) and a ') is about 1 to 7 parts) b) of ethyl acrylate, methyl methacrylate and trimethylammonium ethyl methacrylate. 1:
2: 0.1 copolymer and / or 1: 2: 0.2 copolymer about 0.05 to 0.6 parts c) hydrous alcohol residual amount
【請求項6】 a)及びa’)の共重合体がいずれも平
均分子量約13.5万で、pH7以上の水に溶解する請
求項5記載の皮膚保護剤。
6. The skin protectant according to claim 5, wherein both the copolymers a) and a ′) have an average molecular weight of about 135,000 and are soluble in water having a pH of 7 or more.
【請求項7】 b)の共重合体が平均分子量約15万
で、pH非依存性で水に不溶である請求項5〜6記載の
皮膚保護剤。
7. The skin protectant according to claim 5, wherein the copolymer of b) has an average molecular weight of about 150,000, is pH-independent, and is insoluble in water.
【請求項8】 アルコールがエタノール又はイソプロパ
ノールである請求項5〜7記載の皮膚保護剤。
8. The skin protective agent according to claim 5, wherein the alcohol is ethanol or isopropanol.
JP21281991A 1991-07-30 1991-07-30 Film-type skin protectant Expired - Fee Related JP3212637B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21281991A JP3212637B2 (en) 1991-07-30 1991-07-30 Film-type skin protectant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21281991A JP3212637B2 (en) 1991-07-30 1991-07-30 Film-type skin protectant

Publications (2)

Publication Number Publication Date
JPH0532535A true JPH0532535A (en) 1993-02-09
JP3212637B2 JP3212637B2 (en) 2001-09-25

Family

ID=16628885

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21281991A Expired - Fee Related JP3212637B2 (en) 1991-07-30 1991-07-30 Film-type skin protectant

Country Status (1)

Country Link
JP (1) JP3212637B2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09271293A (en) * 1996-04-03 1997-10-21 Pacific Consultants Kk Animal inhabitation block
JP2008100966A (en) * 2006-10-20 2008-05-01 Kyowa Ltd Skin protecting agent
JP2011126796A (en) * 2009-12-16 2011-06-30 Kracie Home Products Ltd External preparation for hand finger
JP2011126797A (en) * 2009-12-16 2011-06-30 Kracie Home Products Ltd External preparation for hand finger
EP1535938B2 (en) 2003-11-26 2016-11-02 Akzo Nobel N.V. Use of acrylates copolymer as waterproofing agent in personal care applications
WO2020110325A1 (en) * 2018-11-27 2020-06-04 英昌化学工業株式会社 Spray for forming protective film on skin surface
WO2020161771A1 (en) * 2019-02-04 2020-08-13 マルホ株式会社 Skin composition
WO2022030540A1 (en) 2020-08-05 2022-02-10 マルホ株式会社 Skin composition

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09271293A (en) * 1996-04-03 1997-10-21 Pacific Consultants Kk Animal inhabitation block
EP1535938B2 (en) 2003-11-26 2016-11-02 Akzo Nobel N.V. Use of acrylates copolymer as waterproofing agent in personal care applications
JP2008100966A (en) * 2006-10-20 2008-05-01 Kyowa Ltd Skin protecting agent
JP2011126796A (en) * 2009-12-16 2011-06-30 Kracie Home Products Ltd External preparation for hand finger
JP2011126797A (en) * 2009-12-16 2011-06-30 Kracie Home Products Ltd External preparation for hand finger
WO2020110325A1 (en) * 2018-11-27 2020-06-04 英昌化学工業株式会社 Spray for forming protective film on skin surface
WO2020161771A1 (en) * 2019-02-04 2020-08-13 マルホ株式会社 Skin composition
WO2020162402A1 (en) * 2019-02-04 2020-08-13 マルホ株式会社 Skin composition
JPWO2020162402A1 (en) * 2019-02-04 2021-12-16 マルホ株式会社 Skin composition
WO2022030540A1 (en) 2020-08-05 2022-02-10 マルホ株式会社 Skin composition
WO2022029938A1 (en) * 2020-08-05 2022-02-10 マルホ株式会社 Skin composition
KR20230047960A (en) 2020-08-05 2023-04-10 마루호 코 엘티디 composition for skin

Also Published As

Publication number Publication date
JP3212637B2 (en) 2001-09-25

Similar Documents

Publication Publication Date Title
JP4582333B2 (en) Teeth whitening set
AU740615B2 (en) Antipsoriatic nail polish
JP4136036B2 (en) Tooth coating composition
KR950011449B1 (en) Acrylic copolymer and skin protective
WO2004103328A1 (en) Patch for tooth whitening
JP2002104920A (en) Cosmetic composition, and its use as skin cleansing mask
JPH07206711A (en) Composition for treatment of trichophytosis unguium
JP3212637B2 (en) Film-type skin protectant
JP2004067572A (en) Hair cosmetic
HU226246B1 (en) Nail varnish containing glyceril triacetate for treating onychomycoses
KR100673813B1 (en) Gel composition for tooth whitening
JP4887112B2 (en) Skin protectant
JP2974081B2 (en) Aerosol composition for human body
JPH08325128A (en) Long term sustainable base for oral cavity and composition using the same
JPH092943A (en) Film-forming type solution for external use
JP3427445B2 (en) Cream
JPS63104909A (en) Skin protecting agent
JP3157082B2 (en) Base for medical pack-type preparation and pack-type preparation for medical use
JP2004067571A (en) Hair cosmetic
JPH01151516A (en) External drug compounded with vitamin e
JPH08169809A (en) Film type pack
JP2510579B2 (en) Water-in-oil type beauty nail composition
JPH05345712A (en) Pack cosmetic
JPS63108013A (en) Polymer for skin protection
WO1990014076A1 (en) A preparation for the treatment of fungal infections

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080719

Year of fee payment: 7

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090719

Year of fee payment: 8

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 8

Free format text: PAYMENT UNTIL: 20090719

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 9

Free format text: PAYMENT UNTIL: 20100719

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100719

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 10

Free format text: PAYMENT UNTIL: 20110719

LAPS Cancellation because of no payment of annual fees